OM Medispa: Personalized Care Meets Wellness and Beauty ~ Understanding GLP Medications

At OM Medispa, residents can enjoy a truly comprehensive approach to health, wellness, and aesthetic care — all under one roof. From advanced medical skincare and spa services to board-certified family medicine and weight-management programs, OM Medispa blends clinical expertise with a comfortable, supportive experience. 

One standout offering is their GLP program, a medically guided approach to weight loss and metabolic support. Unlike many clinics that prescribe medications without follow-up, OM Medispa ensures each patient receives direct physician oversight, personalized goal setting, and ongoing support, including weekly check-ins that pair medication with nutrition and lifestyle guidance. 

GLP medications have quickly become one of the most talked-about developments in weight loss and metabolic health. Originally prescribed to help manage Type 2 diabetes, these medications are now being used by a growing number of Americans for weight loss—and research continues to show additional benefits for heart, kidney, liver, and brain health.
Currently, there are two FDA-approved GLP medications available: semaglutide and tirzepatide. Both work by mimicking hormones naturally produced in the body to help regulate appetite, blood sugar, and digestion.

Semaglutide: A Proven Option
Semaglutide works by mimicking the GLP-1 hormone, which helps people feel full longer, reduces appetite and cravings, and supports insulin release when needed. It is commonly prescribed for Type 2 diabetes (Ozempic®, Rybelsus®) and weight loss (Wegovy®).

Most patients take semaglutide as a once-weekly injection, though a daily pill version exists. Common side effects—such as nausea, constipation, or diarrhea—are typically mild and improve over time, especially when doses are increased gradually. As with all medications, semaglutide is not appropriate for everyone and should always be taken under medical supervision.

Tirzepatide: A Newer, Dual-Action Medication
Tirzepatide is a newer injectable medication that targets two hormones—GLP-1 and GIP—which is why it often leads to greater weight loss than semaglutide. It is approved for diabetes (Mounjaro®) and weight loss (Zepbound®).

Studies show average weight loss of 15–22% of body weight over about a year, which is significant. Tirzepatide is also taken once weekly and titrated slowly to reduce side effects such as nausea, digestive discomfort, or fatigue. As with semaglutide, lifestyle support plays a critical role in long-term success.

What’s Next: Retatrutide
You may hear buzz online about retatrutide, a next-generation medication currently in clinical trials. It targets three hormones instead of two and has shown impressive early results—but it is not FDA-approved and should not be used outside of trials. Anything marketed as retatrutide today is unregulated and unsafe.

The Big Picture
GLP medications can be powerful tools, but they are not quick fixes. The most successful outcomes occur when medication is paired with lifestyle changes, medical guidance, and ongoing support. Choosing the right option depends on individual health history, goals, and needs.

If you’re curious about whether GLP therapy may be right for you, a personalized medical conversation with OM Medispa is the best place to start—because no two health journeys are the same.